These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1825506)

  • 1. CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules.
    Chvatchko Y; MacDonald HR
    J Exp Med; 1991 Mar; 173(3):779-82. PubMed ID: 1825506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells respond clonally to Mls-1a-encoded determinants.
    MacDonald HR; Lees RK; Chvatchko Y
    J Exp Med; 1990 Apr; 171(4):1381-6. PubMed ID: 2139105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
    Borrero H; Collazo L; Macphail S
    Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.
    Katz ME; Janeway CA
    J Immunol; 1985 Apr; 134(4):2064-70. PubMed ID: 2579126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A characteristic Mls-1a response precedes Mls-1a anergy in vivo.
    Dannecker G; Mecheri S; Staiano-Coico L; Hoffmann MK
    J Immunol; 1991 Apr; 146(7):2083-7. PubMed ID: 1826014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
    Robey E; Ramsdell F; Elliott J; Raulet D; Kioussis D; Axel R; Fowlkes BJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):608-12. PubMed ID: 1824875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of interferon gamma gene expression after activation of CD4+ T cells by conventional antigen and Mls superantigen.
    Patarca R; Wei FY; Iregui MV; Cantor H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2736-9. PubMed ID: 1707172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor lymphocyte stimulating (Mls) gene products in mice influence their genetic resistance or susceptibility to induction of autoimmune encephalomyelitis.
    Ben-Nun A; Soffer D
    Eur J Immunol; 1990 Jan; 20(1):195-200. PubMed ID: 1689661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nomoto K
    J Exp Med; 1990 Jan; 171(1):97-113. PubMed ID: 2136907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human HLA-DQ beta chain presents minor lymphocyte stimulating locus gene products and clonally deletes TCR V beta 6+, V beta 8.1+ T cells in single transgenic mice.
    Zhou P; Anderson GD; Savarirayan S; Inoko H; David CS
    Hum Immunol; 1991 May; 31(1):47-56. PubMed ID: 1908840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. IV. Significance of intrathymic chimerism of blood-born Ia+ cells in Mls tolerance.
    Hosono M; Kurozumi M; Inaba M; Ideyama S; Tomana M; Gyotoku J; Katsura Y; Hosokawa T
    Cell Immunol; 1991 Sep; 136(2):373-87. PubMed ID: 1831406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mls allo-determinants are recognized in an MHC class II antigen-dependent but unrestricted fashion by a discrete set of T cells.
    Macphail S; Stutman O
    J Immunogenet; 1988; 15(1-3):87-99. PubMed ID: 2466909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
    Abe R; Foo-Phillips M; Granger LG; Kanagawa O
    J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell components required for deletion of an autoreactive T cell repertoire.
    Fukushi N; Wang BY; Arase H; Ogasawara K; Good RA; Onoé K
    Eur J Immunol; 1990 May; 20(5):1153-60. PubMed ID: 2113476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.